“Cannabidiol (CBD), a primary bioactive phytocannabinoid extracted from hemp, is reported to possess potent anti-tumorigenic activity in multiple cancers.
However, the effects of CBD on bladder cancer (BC) and the underlying molecular mechanisms are rarely reported.
Here, several experiments proved that CBD promoted BC cells (T24, 5637, and UM-UC-3) death.
In summary, this work demonstrates that CBD may become a novel reliable anticancer drug and the developed intravesical adhesion system is expected to turn into a potential means of BC chemotherapy drug delivery.
We believe that our study makes a significant contribution to the field because these results can be developed as a promising strategy for a safer and more efficient anticancer therapy.”
https://www.mdpi.com/1999-4923/13/9/1415/htm
